Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Enbrel

Enbrel is a medicine containing the active ingredient(s) etanercept. On this page you will find out more about Enbrel, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: etanercept

Pack size information

Please select the pack size from the options directly below to view information on the medicine.

Information for medicine and pack size:
Enbrel (4 x 25 mg vials, 4 x 1 mL inert diluent syringes), 1 pack

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

ENBREL is indicated for the treatment of: Adults Rheumatoid Arthritis Active, adult rheumatoid arthritis (RA) in patients who have had inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs). ENBREL can be used in combination with methotrexate. Severe, active rheumatoid arthritis in adults to slow progression of disease-associated structural damage in patients at high risk of erosive disease. Psoriatic Arthritis The signs and symptoms of active and progressive psoriatic arthritis in adults, when the response to previous disease-modifying antirheumatic therapy has been inadequate. ENBREL has been shown to reduce the rate of progression of joint damage as measured by X-ray and to improve physical function. Plaque Psoriasis Adult patients with moderate to severe chronic plaque psoriasis, who are candidates for phototherapy or systemic therapy. Ankylosing Spondylitis The signs and symptoms of active ankylosing spondylitis in adults. Non-radiographic Axial Spondyloarthritis Treatment of adults with active* non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or MRI change who have had an inadequate response to NSAIDs . * Active disease is defined as a Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score of greater than or equal to 4.,Children and Adolescents Juvenile Idiopathic Arthritis Active polyarthritis (rheumatoid factor positive or negative) in children and adolescents, aged 2 to 17 years, who have had an inadequate response to one or more DMARDs. Active extended oligoarthritis in children and adolescents, aged 2 to 17 years, who have had an inadequate response to, or who have proved intolerant to, methotrexate. Active enthesitis-related arthritis in adolescents, aged 12 to 17 years, who have had an inadequate response to, or who have proved intolerant to, conventional therapy. Active psoriatic arthritis in adolescents, aged 12 to 17 years, who have had an inadequate response to, or who have proved intolerant to, methotrexate. ENBREL has not been studied in children aged less than 2 years. Paediatric Plaque Psoriasis Chronic, severe plaque psoriasis in children and adolescents from 4 to 17 years, who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies. Duration of therapy to be no longer than 24 weeks and treatment to be ceased after 12 weeks if a significant PASI response is not achieved.

Table of characteristics
Table of characteristics
Active ingredient
Medicine schedule
4 vials powder for injection, 4 syringes diluent with 4 needles and 8 alcohol swabs: Prescription Only Medicine, or Prescription Animal Remedy
Part 1
Part 1
Visual appearance CLEAR, COLOURLESS LIQUID.
Dosage Form Diluent, not applicable
Route of administration Subcutaneous
Part 2
Part 2
Visual appearance WHITE CAKE
Dosage Form Injection, powder for
Route of administration Subcutaneous

There is one type of pack available.

Pack type 1
Pack type 1
Type Vial
Storage temperature Store at 2 to 8 degrees Celsius
Storage conditions Do not Freeze,Refrigerate
Life time 4 Years
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 November 2017

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 8 results

Enbrel | myVMC

Enbrel is used to treat rheumatoid arthritis. It contains etanercept a medicine which mediates inflammation and immune responses.

Read more on myVMC – Virtual Medical Centre website

Enbrel Powder for injection - myDr.com.au

Enbrel Powder for injection - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Biologic treatments used in dermatology - ACD

Biologics are medications made from human or animal proteins. They are designed to specifically target biologic pathways that cause inflammation in the skin and other organs.

Read more on Australasian College of Dermatologists website

Juvenile chronic arthritis - myDr.com.au

Juvenile chronic arthritis or juvenile idiopathic arthritis (JIA) is long-term joint inflammation (arthritis) in children. The main symptom is having painful joints for no obvious reason.

Read more on myDr website

Psoriasis: what you need to know - myDr.com.au

Psoriasis is characterised by red scaly patches on the skin that may be sore or itchy. Although there is no cure for psoriasis, in most cases the disease can be well controlled.

Read more on myDr website

Psoriasis Subtypes | myVMC

Psoriasis is a disease which affects multiple systems within the body, predominantly the skin and the joints. Skin disease which can present in multiple different ways and degrees of severity is the hallmark of psoriasis. The severity of psoriasis is defined in terms of how much body surface area and which body parts are involved.

Read more on myVMC – Virtual Medical Centre website

Orencia Powder for infusion - myDr.com.au

Orencia Powder for infusion - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Xeljanz Tablets - myDr.com.au

Xeljanz Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Check your symptoms Find a health service

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback